Wealth Enhancement Advisory Services’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.07M Buy
12,940
+3,286
+34% +$1.84M 0.01% 827
2026
Q1
$5.5M Sell
9,654
-16,040
-62% -$10.3M 0.01% 864
2025
Q4
$18.2M Sell
25,694
-84
-0.3% -$57.2K 0.02% 504
2025
Q3
$16.2M Buy
25,778
+152
+0.6% +$92.3K 0.02% 504
2025
Q2
$14M Buy
25,626
+73
+0.3% +$34.9K 0.02% 529
2025
Q1
$10.7M Buy
25,553
+2,931
+13% +$1.27M 0.02% 560
2024
Q4
$9.35M Sell
22,622
-7,012
-24% -$3.08M 0.02% 580
2024
Q3
$15M Buy
29,634
+19,659
+197% +$9.55M 0.03% 415
2024
Q2
$4.86M Buy
9,975
+4,772
+92% +$2.4M 0.01% 701
2024
Q1
$2.81M Sell
5,203
-1,923
-27% -$1.05M 0.01% 825
2023
Q4
$3.96M Sell
7,126
-85
-1% -$39.9K 0.01% 671
2023
Q3
$3.15M Buy
+7,211
New +$3.6M 0.01% 694
2022
Q4
Sell
-23,320
Closed -$7.77M 346
2022
Q3
$7.77M Buy
23,320
+8,018
+52% +$2.95M 0.11% 92
2022
Q2
$5.79M Buy
+15,302
New +$6.24M 0.08% 115
2021
Q3
Sell
-2,536
Closed -$1.67M 312
2021
Q2
$1.67M Sell
2,536
-193
-7% -$107K 0.03% 149
2021
Q1
$1.34M Buy
2,729
+49
+2% +$24.5K 0.02% 162
2020
Q4
$1.31M Sell
2,680
-3,485
-57% -$1.56M 0.03% 137
2020
Q3
$2.59M Buy
+6,165
New +$2.28M 0.07% 96
2017
Q4
Sell
-5,465
Closed -$869K 156
2017
Q3
$869K Buy
+5,465
New +$864K 0.07% 125

Other funds holding IDXX

Wealth Enhancement Advisory Services's IDXX Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Idexx Laboratories (IDXX) stake by 34% in Q2 2026, buying an estimated $1.84M and bringing the position to 12,940 shares worth $7.07M. The position accounts for 0.01% of the portfolio, ranked #827.

Wealth Enhancement Advisory Services first reported a position in IDXX in Q3 2017 and has held it in 19 quarters since. The position peaked at $18.2M in Q4 2025. 290 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Wealth Enhancement Advisory Services held 12,940 shares of Idexx Laboratories worth $7.07M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 3,286 Idexx Laboratories shares in Q2 2026, an estimated $1.84M.
  • Idexx Laboratories made up 0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #827 holding.
  • Wealth Enhancement Advisory Services first reported a position in Idexx Laboratories in Q3 2017 and has held it in 19 quarters since.
  • Wealth Enhancement Advisory Services's Idexx Laboratories position peaked at $18.2M in Q4 2025.
  • 290 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.